Logo
  • Home
  • About
  • D-VITylation® Technology
  • Pipeline
  • Partnering
  • News
  • Contact

Extend Biosciences’ First Patent has been Awarded by the USPTO

Posted on November 5, 2015

Extend Biosciences’ first patent has been awarded. The patent, titled “Vitamin D-ghrelin Conjugates” issued Nov. 3, 2015 (US 9,173,940).

Latest News

  • Extend Biosciences is Selected to Present in the NIH Innovation Zone at BIO2024
  • A Manuscript on the Preclinical Development of EXT608 Has Been Published
  • Extend Biosciences Becomes a Founding Member of the AmCham Abu Dhabi Biotech Committee
  • Abstract Describing the Phase 1 Clinical Trial Data for EXT608 is Selected for the plenary session at ASBMR
  • FDA’s Office of Orphan Products Development Awards Extend Biosciences Grant Funding to Begin Phase 2a Trials for EXT608

Connect With Us

    footer-logo

    © 2026 Extend Biosciences, Inc. All rights reserved. Website developed by Siphon Marketing